Evidence map›Paper›PMID 36439180›Full record

ReviewFrontiers in immunology2022

The impact of tumor associated macrophages on tumor biology under the lens of mathematical modelling: A review.

Pejman Shojaee, Federica Mornata, Andreas Deutsch, Massimo Locati, Haralampos Hatzikirou

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Immunogenic cell death unlocks the potential for combined radiation and immunotherapy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Spatio-Temporal Dynamics of MBulletin of mathematical biology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Pejman ShojaeeCentre for Information Services and High Performance Computing, Technische Universität (TU) Dresden, Dresden, Germany.
Federica MornataLeukocyte Biology Lab, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Andreas DeutschCentre for Information Services and High Performance Computing, Technische Universität (TU) Dresden, Dresden, Germany.
Massimo LocatiLeukocyte Biology Lab, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Haralampos HatzikirouCentre for Information Services and High Performance Computing, Technische Universität (TU) Dresden, Dresden, Germany.
TU Dresden · DEIRCCS Humanitas Research Hospital · ITKhalifa University of Science and Technology · AEUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article, we review the role of mathematical modelling to elucidate the impact of tumor-associated macrophages (TAMs) in tumor progression and therapy design. We first outline the biology of TAMs, and its current application in tumor therapies, and their experimental methods that provide insights into tumor cell-macrophage interactions. We then focus on the mechanistic mathematical models describing the role of macrophages as drug carriers, the impact of macrophage polarized activation on tumor growth, and the role of tumor microenvironment (TME) parameters on the tumor-macrophage interactions. This review aims to identify the synergies between biological and mathematical approaches that allow us to translate knowledge on fundamental TAMs biology in addressing current clinical challenges.

Indexed as

MacrophagesTumor-Associated MacrophagesBiologyModels, TheoreticalTumor Microenvironmentcancer immunotherapymathematical modellingtumor-associated macrophage (TAM)tumor-macrophage interactionstumor microenvironment (TME)

Identifiers

PMID36439180
PMCPMC9685623
OpenAlexW4308869767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.